Pieter Gillard (Roman Vangoitsenhoven)

ORCID

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 43

Top Venues

Diabetologia

Diabetes technology & therapeutics

Diabetes care

Diabetes, obesity & metabolism

This page only lists publications with an associated author ORCID identifier.

Publications

Margaretha M Visser, Astrid Van Muylder, Sara Charleer, John J Isitt, Stéphane Roze, Christophe De Block, Toon Maes, Gerd Vanhaverbeke, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Jeroen Luyten, Pieter Gillard, Nick Verhaeghe
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium. Diabetologia 67 (4) (2024)
Jolien De Meulemeester, Sara Charleer, Margaretha M Visser, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia (2024)
Chantal Mathieu, Waqas Ahmed, Pieter Gillard, Ohad Cohen, Robert A Vigersky, Simona de Portu, Asli Zeynep Ozdemir Saltik
The Health Economics of Automated Insulin Delivery Systems and the Potential Use of Time in Range in Diabetes Modeling: A Narrative Review. Diabetes technology & therapeutics 26 (S3) (2024)
Margaretha M Visser, Pieter-Jan Martens, Pieter Gillard, Chantal Mathieu
Review Article - Diabetes Technology in the Hospital: An Update. Current diabetes reports 24 (8) (2024)
Margaretha M Visser, Astrid Van Muylder, Sara Charleer, John J Isitt, Stéphane Roze, Christophe De Block, Toon Maes, Gerd Vanhaverbeke, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Jeroen Luyten, Pieter Gillard, Nick Verhaeghe
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium. Diabetologia 67 (4) (2024)
Sara Charleer, Steffen Fieuws, Christophe E M De Block, Nancy Bolsens, Frank Nobels, Kristian Mikkelsen, Chantal Mathieu, Pieter Gillard
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study. Diabetes technology & therapeutics 26 (7) (2024)
Sara Charleer, Steffen Fieuws, Christophe E M De Block, Nancy Bolsens, Frank Nobels, Kristian Mikkelsen, Chantal Mathieu, Pieter Gillard
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study. Diabetes technology & therapeutics (2024)
Nele Steenackers, Thomas Sparsø, Sara Charleer, Christophe E M De Block, Diederik De Cock, Carl Delfin, Chantal Mathieu, Frank Nobels, Sofia Pazmino, Jonathan Rosen, Carmen Hurtado Del Pozo, Pieter Gillard, Bart Van der Schueren
Health-related quality of life of people with type 1 diabetes: An IMI2 SOPHIA post hoc analysis of FUTURE and ADJUNCT-ONE. Diabetes, obesity & metabolism (2024)
Robbe De Groote, Eveline Lefever, Sara Charleer, Phebe Donné, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins. Diabetes technology & therapeutics (2024)
Jolien De Meulemeester, Sara Charleer, Margaretha M Visser, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia 67 (8) (2024)
Jolien De Meulemeester, Sara Charleer, Margaretha M Visser, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study. Diabetologia 67 (8) (2024)
Robbe De Groote, Eveline Lefever, Sara Charleer, Phebe Donné, Christophe E M De Block, Chantal Mathieu, Pieter Gillard
Continuous Glucose Monitoring-Derived Glucometrics in Adults with Type 1 Diabetes When Switching Basal Insulins. Diabetes technology & therapeutics 26 (8) (2024)
Sara Charleer, Steffen Fieuws, Christophe E M De Block, Nancy Bolsens, Frank Nobels, Kristian Mikkelsen, Chantal Mathieu, Pieter Gillard
Evaluation of Glucose Metrics in Adults with Type 1 Diabetes Switching to Insulin Glargine 300 U/mL: A Retrospective, Propensity-Score Matched Study. Diabetes technology & therapeutics 26 (7) (2024)
Margaretha M Visser, Pieter-Jan Martens, Pieter Gillard, Chantal Mathieu
Review Article - Diabetes Technology in the Hospital: An Update. Current diabetes reports 24 (8) (2024)
Margaretha M Visser, Astrid Van Muylder, Sara Charleer, John J Isitt, Stéphane Roze, Christophe De Block, Toon Maes, Gerd Vanhaverbeke, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Jeroen Luyten, Pieter Gillard, Nick Verhaeghe
Cost-utility analysis of Dexcom G6 real-time continuous glucose monitoring versus FreeStyle Libre 1 intermittently scanned continuous glucose monitoring in adults with type 1 diabetes in Belgium. Diabetologia (2024)
Margaretha M Visser, Pieter-Jan Martens, Pieter Gillard, Chantal Mathieu
Review Article - Diabetes Technology in the Hospital: An Update. Current diabetes reports (2024)
Sara Charleer, Christophe E M De Block, Nancy Bolsens, Liesbeth Van Huffel, Frank Nobels, Chantal Mathieu, Pieter Gillard
Sustained Impact of Intermittently Scanned Continuous Glucose Monitoring on Treatment Satisfaction and Severe Hypoglycemia in Adults with Type 1 Diabetes (FUTURE): An Analysis in People with Normal and Impaired Awareness of Hypoglycemia. Diabetes technology & therapeutics (2023)
Marie Yskout, Joke Vliebergh, Hakan Bor, J Dupont Lieven, Natalie Lorent, Pascal Van Bleyenbergh, Pieter Gillard, Bart Van der Schueren, Ann Mertens, Chantal Mathieu, Pieter-Jan Martens
Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes. Case reports in endocrinology 2023 (2023)
Marie Yskout, Joke Vliebergh, Hakan Bor, J Dupont Lieven, Natalie Lorent, Pascal Van Bleyenbergh, Pieter Gillard, Bart Van der Schueren, Ann Mertens, Chantal Mathieu, Pieter-Jan Martens
Hypoglycaemia after Initiation of CFTR Modulator Therapy in a Cystic Fibrosis Patient without Diabetes. Case reports in endocrinology 2023 (2023)
Julie Vandewalle, Aster K Desouter, Bart J Van der Auwera, Sylvie Tenoutasse, Pieter Gillard, Christophe De Block, Bart Keymeulen, Frans K Gorus, Mark Van de Casteele, null null
CTLA4, SH2B3 and CLEC16A diversely affect the progression of early islet autoimmunity in relatives of type 1 diabetes patients. Clinical and experimental immunology (2023)
Laura M Jacobsen, Jennifer L Sherr, Elizabeth G Considine, Angela Chen, Sarah M Peeling, Margo Hulsmans, Sara Charleer, Marzhan Urazbayeva, Mustafa Tosur, Selma Alamarie, Maria J Redondo, Korey K Hood, Peter A Gottlieb, Pieter Gillard, Jessie J Wong, Irl B Hirsch, Richard E Pratley, Lori M Laffel, Chantal Mathieu, null null
Utility and precision evidence of technology in the treatment of type 1 diabetes: a systematic review. Communications medicine 3 (1) (2023)
Margaretha Martha Visser, Sara Charleer, Steffen Fieuws, Christophe De Block, Robert Hilbrands, Liesbeth Van Huffel, Toon Maes, Gerd Vanhaverbeke, Eveline Dirinck, Nele Myngheer, Chris Vercammen, Frank Nobels, Bart Keymeulen, Chantal Mathieu, Pieter Gillard
The Impact of Baseline User Characteristics on the Benefits of Real-Time Versus Intermittently Scanned Continuous Glucose Monitoring in Adults With Type 1 Diabetes: Moderator Analyses of the ALERTT1 Trial. Journal of diabetes science and technology (2022)
Sophie Van Aelst, Pieter Gillard, Ilse Weets, Doreen Dillaerts, Jaak Billen, Chantal Mathieu, Xavier Bossuyt
Pancreas Islet Cell-Specific Antibody Detection by ELISA. The journal of applied laboratory medicine 7 (1) (2022)
Peter Rossing, Ellen Burgess, Rajiv Agarwal, Stefan D Anker, Gerasimos Filippatos, Bertram Pitt, Luis M Ruilope, Pieter Gillard, Richard J MacIsaac, Julio Wainstein, Amer Joseph, Meike Brinker, Lothar Roessig, Charlie Scott, George L Bakris, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null, null null
Finerenone in Patients With Chronic Kidney Disease and Type 2 Diabetes According to Baseline HbA1c and Insulin Use: An Analysis From the FIDELIO-DKD Study. Diabetes care 45 (4) (2022)
Lorenzo Piemonti, Bart Keymeulen, Pieter Gillard, Thomas Linn, Emanuele Bosi, Ludger Rose, Pozzilli Paolo, Francesco Giorgino, Efisio Cossu, Luisa Daffonchio, Giovanni Goisis, Pier Adelchi Ruffini, Anna Rita Maurizi, Flavio Mantelli, Marcello Allegretti
Ladarixin, an inhibitor of the interleukin-8 receptors CXCR1 and CXCR2, in new-onset type 1 diabetes: A multicentre, randomized, double-blind, placebo-controlled trial. Diabetes, obesity & metabolism 24 (9) (2022)
Margaretha M Visser, Chantal Mathieu, Pieter Gillard
Diabetic Ketoacidosis After Sodium-Glucose Cotransporter Inhibitor Initiation Under Advanced Hybrid Closed-Loop Therapy in Type 1 Diabetes. Diabetes technology & therapeutics 24 (7) (2022)
Ben Broos, Sara Charleer, Nancy Bolsens, Carolien Moyson, Chantal Mathieu, Pieter Gillard, Christophe E M De Block
Diabetes Knowledge and Metabolic Control in Type 1 Diabetes Starting With Continuous Glucose Monitoring: FUTURE-PEAK. The Journal of clinical endocrinology and metabolism 106 (8) (2021)
Lisa Billion, Sara Charleer, Laurens Verbraeken, Mira Sterckx, Kato Vangelabbeek, Nathalie De Block, Charlien Janssen, Kristof Van Dessel, Eveline Lia Dirinck, Frida Peiffer, Nancy Bolsens, Chantal Mathieu, Pieter Gillard, Christophe E M De Block
Glucose control using fast-acting insulin aspart in a real-world setting: A 1-year, two-centre study in people with type 1 diabetes using continuous glucose monitoring. Diabetes, obesity & metabolism 23 (12) (2021)
Katrien Benhalima, Falco van Nes, Annouschka Laenen, Pieter Gillard, Chantal Mathieu
Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT. Diabetologia 64 (12) (2021)
Anass El Malahi, Michiel Van Elsen, Sara Charleer, Eveline Lia Dirinck, Kristien J Ledeganck, Bart Keymeulen, Laurent Crenier, Régis Pierre Radermecker, Youri Taes, Chris Vercammen, Frank Nobels, Chantal Mathieu, Pieter Gillard, Christophe E M De Block
Relationship between time in range, glycemic variability, HbA1c and complications in adults with type 1 diabetes mellitus. The Journal of clinical endocrinology and metabolism (2021)
Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Remi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nicholas S Oliver, Dessi P Zaharieva, Tadej Battelino, Carine de Beaufort, Richard M Bergenstal, Bruce A Buckingham, Eda Cengiz, Asma Deeb, Tim Heise, Simon R Heller, Aaron J Kowalski, Lalantha Leelarathna, Chantal Mathieu, Christoph Stettler, Martin Tauschmann, Hood Thabit, Emma G Wilmot, Harald Sourij, Carmel E M Smart, Peter G Jacobs, Richard M Bracken, Julia Katharina Mader
Glucose management for exercise using continuous glucose monitoring (CGM) and intermittently scanned CGM (isCGM) systems in type 1 diabetes: position statement of the European Association for the Study of Diabetes (EASD) and of the International Society for Pediatric and Adolescent Diabetes (ISPAD) endorsed by JDRF and supported by the American Diabetes Association (ADA). Diabetologia 63 (12) (2021)
Othmar Moser, Michael C Riddell, Max L Eckstein, Peter Adolfsson, Remi Rabasa-Lhoret, Louisa van den Boom, Pieter Gillard, Kirsten Nørgaard, Nicholas S Oliver, Dessi P Zaharieva, Tadej Battelino, Carine de Beaufort, Richard M Bergenstal, Bruce A Buckingham, Eda Cengiz, Asma Deeb, Tim Heise, Simon R Heller, Aaron J Kowalski, Lalantha Leelarathna, Chantal Mathieu, Christoph Stettler, Martin Tauschmann, Hood Thabit, Emma G Wilmot, Harald Sourij, Carmel E M Smart, Peter G Jacobs, Richard M Bracken, Julia Katharina Mader
Glucose management for exercise using continuous glucose monitoring: should sex and prandial state be additional considerations? Reply to Yardley JE and Sigal RJ [letter]. Diabetologia 64 (4) (2021)
Julie Vandewalle, Bart J Van der Auwera, Henna Amin, Erik Quartier, Aster K Desouter, Sylvie Tenoutasse, Pieter Gillard, Christophe E M De Block, Bart Keymeulen, Frans K Gorus, Mark Van de Casteele, null null
Genetic variation at ERBB3/IKZF4 and sexual dimorphism in epitope spreading in single autoantibody-positive relatives. Diabetologia 64 (11) (2021)
Freya Van Hulle, Kaat De Groot, Robert Hilbrands, Ursule Van de Velde, Krista G Suenens, Geert Stangé, Ines De Mesmaeker, Diedert Luc De Paep, Zhidong Ling, Bart O Roep, Pieter Gillard, Daniel G Pipeleers, Bart Keymeulen, Daniel Jacobs-Tulleneers Thevissen
Function and composition of pancreatic islet cell implants in omentum of type 1 diabetes patients. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons (2021)
Freya Van Hulle, Kaat De Groot, Geert Stangé, Krista Suenens, Ines De Mesmaeker, Diedert Luc De Paep, Zhidong Ling, Robert Hilbrands, Pieter Gillard, Bart Keymeulen, Evert J Kroon, Gunilla T Westermark, Daniel Jacobs-Tulleneers Thevissen, Daniel G Pipeleers
Formation of amyloid in encapsulated human pancreatic and human stem cell-generated beta cell implants. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 21 (6) (2020)
Sara Charleer, Christophe De Block, Frank Nobels, Régis P Radermecker, Ine Lowyck, Annelies Mullens, Denis Scarnière, Katrien Spincemaille, Marie Strivay, Eric Weber, Youri Taes, Chris Vercammen, Bart Keymeulen, Chantal Mathieu, Pieter Gillard, null null
Sustained Impact of Real-time Continuous Glucose Monitoring in Adults With Type 1 Diabetes on Insulin Pump Therapy: Results After the 24-Month RESCUE Study. Diabetes care 43 (12) (2020)
Diedert Luc De Paep, Pieter Gillard, Zhidong Ling, Hilde Verbeke, Geert Maleux, Vincent Vandecaveye, Yves Debaveye, Bart Keymeulen, Schalk Willem Van der Merwe, Daniel G Pipeleers, Jacques Pirenne, Hannah van Malenstein, Daniel Jacobs-Tulleneers Thevissen
Use of hyperglycemic clamp to assess pancreatectomy and islet cell autotransplant in patient with heterotaxy syndrome and dorsal pancreas agenesis leading to chronic pancreatitis. American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons 20 (12) (2020)
Pieter Gillard, Pieter-Jan Martens, Falco van Nes, Carolien Moyson, Frank Nobels, Paul Van Crombrugge, Katrien Wierckx, Inge van Pottelbergh, Liesbeth Van Huffel, Pieter Gillard, Chantal Mathieu
No Evidence of Increased Hospitalization Rate for COVID-19 in Community-Dwelling Patients With Type 1 Diabetes. Diabetes care 43 (10) (2020)
Bart Keymeulen, André van Maurik, Dave Inman, João Oliveira, Rene McLaughlin, Rachel M Gittelman, Bart O Roep, Pieter Gillard, Robert Hilbrands, Frans K Gorus, Chantal Mathieu, Ursule Van de Velde, Nicolas Wisniacki, Antonella Napolitano
A randomised, single-blind, placebo-controlled, dose-finding safety and tolerability study of the anti-CD3 monoclonal antibody otelixizumab in new-onset type 1 diabetes. Diabetologia 64 (2) (2020)
Sara Charleer, Christophe E M De Block, Liesbeth Van Huffel, Ben Broos, Steffen Fieuws, Frank Nobels, Chantal Mathieu, Pieter Gillard
Quality of Life and Glucose Control After 1 Year of Nationwide Reimbursement of Intermittently Scanned Continuous Glucose Monitoring in Adults Living With Type 1 Diabetes (FUTURE): A Prospective Observational Real-World Cohort Study. Diabetes care 43 (2) (2019)
Maarten Coemans, Elisabet Van Loon, Evelyne Lerut, Pieter Gillard, Ben Sprangers, Aleksandar Senev, Marie-Paule Emonds, Jan Van Keer, Jasper Callemeyn, Liesbeth Daniëls, Jeroen Sichien, Geert Verbeke, Dirk Kuypers, Chantal Mathieu, Maarten Naesens
Occurrence of Diabetic Nephropathy After Renal Transplantation Despite Intensive Glycemic Control: An Observational Cohort Study. Diabetes care 42 (4) (2019)
Chantal Mathieu, Paresh Dandona, Pieter Gillard, Peter Senior, Christoph Hasslacher, Eiichi Araki, Marcus Lind, Stephen C Bain, Serge A Jabbour, Niki Arya, Lars Hansen, Fredrik Thorén, Anna Maria Langkilde, null null
Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial. Diabetes care 41 (9) (2018)
Sara Charleer, Chantal Mathieu, Frank Nobels, Pieter Gillard
Accuracy and precision of flash glucose monitoring sensors inserted into the abdomen and upper thigh compared with the upper arm. Diabetes, obesity & metabolism 20 (6) (2018)

Pieter Gillard.css-eqlu8i{font-size:small;padding-left:4px;} (Roman Vangoitsenhoven)

Publication Activity (10 Years)

Top Topics

Top Venues

Pieter Gillard (Roman Vangoitsenhoven)